PMX 205
NRP1 antagonist 1
Zilucoplan
Tesidolumab
Lampalizumab
Avdoralimab
Vesencumab
Ravulizumab
Pexelizumab
Vilobelimab
Gavilimomab
Gefurulimab
Pozelimab
Olendalizumab
Crovalimab
Riliprubart
Empasiprubart
Zoracopan
BCX 1470
Sutimlimab